Morganti, Alessio Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 7.058
NA - Nord America 6.349
AS - Asia 1.527
AF - Africa 73
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 13
Totale 15.057
Nazione #
US - Stati Uniti d'America 6.255
DE - Germania 3.110
SE - Svezia 1.263
CN - Cina 901
UA - Ucraina 627
IT - Italia 545
IE - Irlanda 330
FR - Francia 285
GB - Regno Unito 244
SG - Singapore 235
FI - Finlandia 173
IN - India 157
PL - Polonia 148
RU - Federazione Russa 127
TR - Turchia 103
CA - Canada 88
CI - Costa d'Avorio 65
BE - Belgio 62
CZ - Repubblica Ceca 52
JP - Giappone 35
IR - Iran 32
NL - Olanda 26
HK - Hong Kong 24
VN - Vietnam 16
EU - Europa 12
AU - Australia 11
RO - Romania 11
ES - Italia 10
CH - Svizzera 7
CL - Cile 7
EG - Egitto 6
PT - Portogallo 6
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
GR - Grecia 4
IL - Israele 4
AR - Argentina 3
BR - Brasile 3
DK - Danimarca 3
HU - Ungheria 3
LK - Sri Lanka 3
MX - Messico 3
MY - Malesia 3
PE - Perù 3
A1 - Anonimo 2
EC - Ecuador 2
HR - Croazia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
BD - Bangladesh 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
ID - Indonesia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 15.057
Città #
Chandler 1.538
Ashburn 494
Jacksonville 385
Dublin 328
San Mateo 310
Nanjing 230
Dearborn 216
Ann Arbor 215
Wilmington 192
Nürnberg 183
Woodbridge 153
New York 149
Boston 147
Warsaw 145
Singapore 138
Milan 129
Bremen 127
Marseille 118
Lawrence 103
Izmir 101
Beijing 95
Nanchang 92
Cattolica 89
Princeton 85
Moscow 84
Houston 80
Fairfield 77
Redwood City 71
Abidjan 65
Brussels 62
Leawood 61
Seattle 60
Rome 58
Helsinki 53
Munich 46
Zhengzhou 44
North York 42
Boardman 41
University Park 39
Kunming 37
Hebei 36
Shenyang 36
Jiaxing 35
Los Angeles 35
Toronto 35
Augusta 34
Fremont 32
Changsha 29
Tianjin 29
Phoenixville 28
Cambridge 27
Mountain View 26
Norwalk 26
Detroit 24
Lancaster 24
Auburn Hills 23
Brno 21
Hangzhou 21
Pune 21
Washington 19
Falls Church 18
Guangzhou 17
Redmond 16
Amsterdam 15
Hanoi 15
Monmouth Junction 15
Shanghai 15
Edinburgh 13
Lanzhou 13
Enterprise 12
Hong Kong 12
Andover 11
Hefei 11
Jinan 11
Ardabil 9
Chicago 9
Indiana 9
San Francisco 9
Dresden 8
Sacramento 8
Bari 7
Central District 7
Costa Mesa 7
Ningbo 7
Sergii 7
Simi Valley 7
Tokyo 7
Wuhan 7
Arezzo 6
Berlin 6
Kish 6
Landshut 6
London 6
Mumbai 6
Phoenix 6
Bologna 5
Chengdu 5
Saint Paul 5
Turin 5
Zanjan 5
Totale 7.612
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 792
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 250
A National project for in vivo dosimetry procedures in radiotherapy: First results 245
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 231
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 168
A National project for in vivo dosimetry procedures in radiotherapy: First results 165
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 161
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 158
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 158
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 144
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 140
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 138
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 135
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 134
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 134
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 133
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 131
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 130
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 129
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 125
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 125
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 124
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 123
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 123
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 123
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 123
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 122
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 122
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 122
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 121
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 119
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 118
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 117
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 116
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 115
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 112
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 110
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 108
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 108
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 108
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 107
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 107
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 106
In Vivo Portal Dosimetry by an Ionization Chamber 105
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 105
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 105
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 105
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 105
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 104
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 102
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 99
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 99
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 98
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 98
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 98
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 98
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 97
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 95
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 95
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 94
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 94
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 93
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 92
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 91
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 91
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 90
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 90
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 90
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 88
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 88
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 88
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 86
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 86
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 85
Real time transit dosimetry for the breath-hold radiotherapy technique experience 84
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 83
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 82
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 81
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 81
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 81
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 81
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 81
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 80
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 80
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 79
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 79
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 79
Preoperative chemoradiation with raltitrexed (Tomudex) in T2/N+ and T3/N+ rectal cancers: a phase I study. 78
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 77
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 77
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 76
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 75
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 74
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 74
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 72
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 72
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 71
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 71
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 71
Totale 11.476
Categoria #
all - tutte 56.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.392 361 145 106 99 217 223 298 136 216 163 265 163
2020/20211.452 81 171 30 156 204 64 140 42 167 107 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/202591 91 0 0 0 0 0 0 0 0 0 0 0
Totale 15.731